PEBP1 and neoplasm: Taken together, RKIP exerts cardiotoxic effects by multiple pathways (i) as a tumour metastasis suppressor and inhibitor of the RAF1-MAPK axis and (ii) as a GRK2 inhibitor (Figure 7).